No products in the cart.
Clinical Guide To Angio-Oct: Non Invasive, Dyeless Oct Angiography
Roll over image to zoom in
₹2,620.00₹3,275.00 (-20%)
Author : Bruno Lumbroso
ISBN : 9789351523994
Publisher : Jaypee Brothers Medical Publishers (P) Ltd
Edition : 1st
Year : 2015
Pages : 100
Product Type : Hard Cover
Condition : New
Compare
- Angio-OCT (Dyeless OCT Angiography) is a new technology that gives already useful results, that can be applied to day-to-day clinical ophthalmology. Several different OCT Angiography prototypes are developing, but only XR-Avanti Optovue with split-spectrum amplitude-decorrelation angiography (SSADA) algorithm is available clinically. Dyeless OCT Angiography is fast, easy, non invasive.
- The aim of Clinical Guide to Angio-OCT (Non Invasive, Dyeless OCT Angiography) is to show everyday OCT user the clinical utility of OCT angiography. David Huang and Yali Jia present the SSADA algorithm and its applications in choroidal neovascularization (CNV), optic disk disorders and glaucoma. James G Fujimoto and Bruno Lumbroso propose the new terminology necessary to study this new technology. Clinical ophthalmologists, technicians and optometrists will find an OCT angiography atlas of the general syndromes and clinical signs. Then we present technological or scientific Angio-OCT progresses and its clinical applications.
- The book discusses the clinical possibilities of OCT Angiography. It will guide the basic ophthalmologists or technicians to understand the new imaging typical and atypical aspects. The book will support to develop interest in using Angio-OCT in normal clinical work, to show Angio-OCT users the practical clinical interest in everyday ophthalmology, help users in understanding Angio-OCT. Most imaging (77 figures) has been performed with XR-Avanti Optovue SD-OCT device using SSADA algorithm.
Additional information
| Weight | 0.6 kg |
|---|---|
| Dimensions | 25 × 20 × 5 cm |
No more offers for this product!
General Inquiries
There are no inquiries yet.
Reviews
There are no reviews yet.